# Prescription and Persistence of Antithrombotic Agents in Acute Ischemic Stroke or Transient Ischemic Attack Patients With MCA(Middle Cerebral Artery) Disease

> **NCT02953405** · — · UNKNOWN · sponsor: **Daewoong Pharmaceutical Co. LTD.** · enrollment: 1000 (estimated)

## Conditions studied

- MCA - Middle Cerebral Artery Dissection

## Interventions

- **DRUG:** Clopidogrel

## Key facts

- **NCT ID:** NCT02953405
- **Lead sponsor:** Daewoong Pharmaceutical Co. LTD.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-12
- **Primary completion:** 2018-11
- **Final completion:** 2018-11
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2016-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02953405

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02953405, "Prescription and Persistence of Antithrombotic Agents in Acute Ischemic Stroke or Transient Ischemic Attack Patients With MCA(Middle Cerebral Artery) Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02953405. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*